New York, Jan. 21, 2016 --
AlphaPoint today announced that industry veteran Scott Scalf has joined its executive team. Scalf, former Director of Trade Lifecycle Systems at Deutsche Bank Global Technology, joins the company as Executive Vice President of Development Operations.
“The financial sector is undergoing a profound technological shift as firms and institutions embrace the blockchain and related technologies. More than ever, it’s important that veteran leadership helps drive innovation in the space,” said Joe Ventura, Founder of AlphaPoint. “With more than 25 years of engineering and management experience, Scott has a deep understanding not only of existing market infrastructure, but of our firm’s vision of what will come next, and he will be key to AlphaPoint’s continued growth.”
Mr. Scalf brings a wealth of experience engineering and managing both front- and back-office systems for both buy-side and sell-side firms: OMS/EMS, algorithmic execution, real-time position and risk, dynamic trading surveillance, post-trade processing, clearing & settlement, and regulatory reporting. Scott’s previous roles include Head of Enterprise Technology and Head of Institutional Brokerage Technology at Susquehanna International Group, Director of Trade Lifecycle Systems at Deutsche Bank, and CTO and founder of S3 Consulting.
Scott’s teams have successfully designed and delivered systems for multiple Wall Street institutions, including Merrill Lynch, Charles Schwab, Deutsche Bank, SIG, and others. Throughout his career, Scott has focused on high-performance, high-throughput distributed systems; he holds two patents for proprietary asymmetric middleware optimized for massively concurrent web applications.
“World-class FinTech requires both a deep understanding of the domain and outstanding engineering capabilities - and AlphaPoint has both,” said Scott Scalf. “I am thrilled to be involved at this innovative stage to help the AlphaPoint team build the trusted infrastructure needed to realize the potential blockchain technology, digital assets, and distributed ledgers hold for capital markets and beyond.”
About AlphaPoint
AlphaPoint is a financial technology company that powers digital asset exchanges and provides institutions blockchain-enabled solutions to store, track, and trade digital assets. Its secure, scalable, and customizable platform can process nearly 1 million transactions per second, enabling customers to innovate, differentiate, and transform their businesses. As the world's leading white label exchange provider, AlphaPoint powers over 20 digital asset exchanges on 5 continents, and is led by a seasoned team with 50+ years in financial technology. AlphaPoint has offices in New York City, Philadelphia, and San Francisco.
Michael Haley :: [email protected]


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



